scholarly journals COMPARISON OF BETA-ADRENERGIC BLOCKING EFFECT OF DCI, METHOXAMINE, PROPRANOLOL, MJ 1999, H 56/28, LB 46 AND I.C.I. 50 172 ON THE CHRONOTROPIC RESPONSE TO ISOPRENALINE

1970 ◽  
Vol 20 (2) ◽  
pp. 294-304 ◽  
Author(s):  
KAZUHIRO OHKUDA ◽  
SHIGETOSHI CHIBA ◽  
NORIO TAIRA ◽  
KOROKU HASHIMOTO
2014 ◽  
Vol 11 (3) ◽  
pp. 83-87
Author(s):  
O M Mikheeva ◽  
I A Komisarenko

Beta-adrenergic blocking agent is included in the group of primary agentsfor treatment of patients with AH. In the pathogenesis of AH,one of the main causes leading to raisingthe blood pressure isendothelial dysfunction.Correction ofendothelial dysfunctionis AH treatment strategic aim.Nebivololis a cardioselectivethird-generationvasodilatingβ-adrenergic blocking agent, which is in addition toβ-adrenergic blocking effect, can alsoincrease endogenousproduction of NOin the endothelial cellsdue to the decreasing of oxidative degradation. As a result,nebivololprovides positivehemodynamic effects on patients with AH, decreasingperipheral resistanceandblood pressure.


1980 ◽  
Vol 1 (1) ◽  
pp. 30-31 ◽  
Author(s):  
J. H. N. Bett ◽  
R. K. Wilkinson ◽  
J. Williams ◽  
H. Ryan

1967 ◽  
Vol 139 (3 New Adrenergi) ◽  
pp. 952-967 ◽  
Author(s):  
Stephen E. Epstein ◽  
Eugene Braunwald

1975 ◽  
Vol 18 (2) ◽  
pp. 148-152 ◽  
Author(s):  
Milton L. Hoefle ◽  
Stephen G. Hastings ◽  
Robert F. Meyer ◽  
Ruth M. Corey ◽  
Ann Holmes ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document